alexa Hodgkins lymphoma | Ireland| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Hodgkins Lymphoma

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Hodgkins lymphoma

    Hodgkin disease: This is a cancer that develops in the lymph system (lymphoma), part of the body's immune system. Because there is lymph tissue in many areas of the body, Hodgkin disease can start in almost any part of the body

  • Hodgkins lymphoma

    The disease most often develops on the background of good health and the absence of any complaints. Mild and non-permanent signs of the disease may hinder early diagnosis. The main symptoms of Hodgkin's lymphoma which causes the patient to seek medical attention are: Painless swelling of subcutaneous lymph nodes in the neck, armpits or groin, Cough and shortness of breath. e and weakness, Periodic hyperthermia, often accompanied by chills, Night sweats, , Decreased appetite and significant weight loss, Increased sensitivity to the effects of alcohol, which is manifested by pain in the lymph nodes after its use Repeated bacterial, viral and fungal infections characterized by its severity.

  • Hodgkins lymphoma

    Treatment of Hodgkin lymphoma is tailored to disease type, disease stage, and an assessment of the risk of resistant disease. Hodgkin lymphoma is considered to be a curable malignancy, but therapies for this disease can have significant long-term toxicity. General treatment modalities include radiation therapy, induction chemotherapy, India presents a significant male predominance in HD that much higher than in any other types of childhood cancers. For instance, a seven-year study of 617 cases of childhood cancers registered in Bangalore showed a M : F ratio of 1.8:1, whereas the 54 cases of childhood HD had a M : F ratio of 7.8:1. Likewise, the analysis of childhood cancers registered in All India Institute of Medical Sciences during a 5-year period showed a M : F ratio of 7.4:1 in HD, against M:F ratios in other cancers between 2:1 (neuroblastoma and retinoblastoma) and 4.0:1 (acute myeloid leukemia) (unpublished data). Similarly, childhood HD in Mumbai presents a M : F ratio of 6:1  

Speaker PPTs


High Impact List of Articles

Conference Proceedings